PAX Financial Group LLC Sells 2,131 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

PAX Financial Group LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 79.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 568 shares of the medical equipment provider’s stock after selling 2,131 shares during the quarter. PAX Financial Group LLC’s holdings in Intuitive Surgical were worth $281,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ISRG. Norges Bank bought a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $2,401,493,000. GAMMA Investing LLC raised its holdings in Intuitive Surgical by 54,010.7% during the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider’s stock valued at $14,999,630,000 after buying an additional 3,022,979 shares during the period. Capital Research Global Investors raised its holdings in Intuitive Surgical by 25.5% during the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock valued at $1,764,904,000 after buying an additional 687,906 shares during the period. Northern Trust Corp raised its holdings in Intuitive Surgical by 15.8% during the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider’s stock valued at $1,889,126,000 after buying an additional 494,496 shares during the period. Finally, Vanguard Group Inc. raised its holdings in Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after buying an additional 360,591 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $512.23 on Wednesday. Intuitive Surgical, Inc. has a 1-year low of $413.82 and a 1-year high of $616.00. The stock’s 50-day moving average is $537.18 and its 200 day moving average is $536.37. The company has a market cap of $183.59 billion, a P/E ratio of 75.11, a PEG ratio of 5.48 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter last year, the company earned $1.50 earnings per share. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analysts Set New Price Targets

Several analysts recently weighed in on ISRG shares. Truist Financial decreased their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a report on Wednesday, April 23rd. Royal Bank Of Canada reduced their target price on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. Citigroup reiterated a “buy” rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Piper Sandler reduced their target price on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 23rd. Finally, Evercore ISI increased their target price on Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 8th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $592.86.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of the firm’s stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director owned 6,371 shares of the company’s stock, valued at approximately $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the sale, the executive vice president directly owned 5,224 shares of the company’s stock, valued at approximately $2,695,113.84. This represents a 3.47% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 4,998 shares of company stock worth $2,611,577 in the last three months. Insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.